MedTech News
Sofinnova spinoff Tulyp Medical emerges from stealth with perfusion tech
Having already submitted an application with the FDA, Tulyp is now eyeing a Series A financing round to capture more clinical data and advance R&D.
Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes
Aqua Medical has received an investigational device exemption (IDE) from the FDA for its ablation device intended to treat diabetes, the company told MassDevice ahead of an official announcement later today.
Fujifilm Sonosite launches new clamshell portable ultrasound system
Fujifilm Sonosite announced today that it launched the Sonosite MT, its latest portable ultrasound system offering.
Bioelectrochemical crossbar architecture screening platform for extracellular electron transfer
Bioelectronic devices link microbes and materials to convert chemical signals into electrical outputs for sensing, energy, and synthesis. Unlocking this potential requires systems that can interrogate electroactive cells rapidly and at scale, but traditional bioelectrochemical platforms remain costly, bulky, and low throughput.
Self-aligning mechanism for wearable biomechanical energy harvesters
The increasing demand for real-time, wireless, and sustainable motion monitoring in applications such as personal health, professional sports, and human-machine interactions calls for wearable devices that are lightweight and battery free.
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — The U.S. Food and Drug Administration (“FDA”) has granted QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global leader of in vitro diagnostics, 510(k) clearance for the VITROS hs Troponin I Reagent Pack (the “VITROS hs Troponin I Assay”). The assay is intended for the quantitative measurement of cardiac troponin I (cTnI) in human plasma (heparin) to aid in the diagnosis of myocardial infarction (MI).
EmeTerm Wristband Significantly Reduces Postoperative Nausea and Vomiting in Major Orthopedic Surgeries
VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomiting (PONV) in patients undergoing total hip or knee arthroplasty (THA/TKA) under spinal anesthesia.
Biosensor technology may lead to breath test for lung cancer
University of Texas at Dallas researchers have developed biosensor technology that, when combined with artificial intelligence (AI), shows promise for detecting lung cancer through breath analysis.